Real adoption across regulated industries
Privacy-first AI software with a live clinical-technology deployment at Translyx, plus onboarding and pipeline engagements across oncology, public health, and women's health in New Zealand, the United States, and South Asia.
Adoption status
Where Privexa is being used today
Each engagement is shown at its current stage. We name organisations only where we have permission to do so; other engagements are described without identifying details.
Featured engagement
Moffitt Cancer Center
Florida's first NCI-designated Comprehensive Cancer Center
- NCI-designated Comprehensive Cancer Center
- One of ~30 U.S. centers in the NCCN
- Dedicated to cancer treatment and research only
Following a successful product demonstration, Moffitt Cancer Center is progressing into onboarding for a fully on-premise Privexa deployment — keeping patient data and proprietary research within Moffitt's own infrastructure at all times. Agreement and integration documentation are currently in progress.
Translyx
Translyx uses Privexa-built privacy-first software to support healthcare, diagnostics, and governed clinical-technology adoption across New Zealand and Oceania.
A national health service in New Zealand
A referral-grading tool is being built for a national health service, with a Privexa privacy and governance layer planned for integration to keep clinical data protected and auditable.
A women's health & antenatal-care clinic
A women's health and antenatal-care clinic is evaluating Privexa for gynecology referral grading and privacy-protected clinical documentation within its existing workflow.
Adoption stage reflects the current engagement and may change over time. Named references are used with permission; other engagements are described without identifying details. Regulatory status and intended use vary by product and jurisdiction.
How adoption works
Governed from first demo to production
Every Privexa engagement is built around controlled AI adoption: sensitive data is protected, processing runs through authorised workflows, and every step stays reviewable. The same safeguards apply whether a team is evaluating, onboarding, or live in production.
Human review and reviewer gates
Field-level data protection
Lineage and audit trails
Deployment-specific governance
Authorised access only
Visible limitations
Become the next Privexa deployment
Talk to Privexa about protected AI gateways, clinical workflow software, or referral-grading tools for your regulated team.